These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37018391)

  • 1.
    Ferrari-Souza JP; Lussier FZ; Leffa DT; Therriault J; Tissot C; Bellaver B; Ferreira PCL; Malpetti M; Wang YT; Povala G; Benedet AL; Ashton NJ; Chamoun M; Servaes S; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; O'Brien JT; Rowe JB; Cohen AD; Lopez OL; Tudorascu DL; Karikari TK; Klunk WE; Villemagne VL; Soucy JP; Gauthier S; Souza DO; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
    Sci Adv; 2023 Apr; 9(14):eade1474. PubMed ID: 37018391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
    Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOEε4 potentiates amyloid β effects on longitudinal tau pathology.
    Ferrari-Souza JP; Bellaver B; Ferreira PCL; Benedet AL; Povala G; Lussier FZ; Leffa DT; Therriault J; Tissot C; Soares C; Wang YT; Chamoun M; Servaes S; Macedo AC; Vermeiren M; Bezgin G; Kang MS; Stevenson J; Rahmouni N; Pallen V; Poltronetti NM; Cohen A; Lopez OL; Klunk WE; Soucy JP; Gauthier S; Souza DO; Triana-Baltzer G; Saad ZS; Kolb HC; Karikari TK; Villemagne VL; Tudorascu DL; Ashton NJ; Zetterberg H; Blennow K; Zimmer ER; Rosa-Neto P; Pascoal TA
    Nat Aging; 2023 Oct; 3(10):1210-1218. PubMed ID: 37749258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE effects on regional tau in preclinical Alzheimer's disease.
    Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ;
    Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of APOE ε4 genotype on amyloid-β and tau accumulation in Alzheimer's disease.
    Baek MS; Cho H; Lee HS; Lee JH; Ryu YH; Lyoo CH
    Alzheimers Res Ther; 2020 Oct; 12(1):140. PubMed ID: 33129364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer's disease.
    Cai Y; Du J; Li A; Zhu Y; Xu L; Sun K; Ma S; Guo T;
    Alzheimers Res Ther; 2023 Feb; 15(1):30. PubMed ID: 36750884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.
    Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW
    J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglial activation and tau propagate jointly across Braak stages.
    Pascoal TA; Benedet AL; Ashton NJ; Kang MS; Therriault J; Chamoun M; Savard M; Lussier FZ; Tissot C; Karikari TK; Ottoy J; Mathotaarachchi S; Stevenson J; Massarweh G; Schöll M; de Leon MJ; Soucy JP; Edison P; Blennow K; Zetterberg H; Gauthier S; Rosa-Neto P
    Nat Med; 2021 Sep; 27(9):1592-1599. PubMed ID: 34446931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
    Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
    JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respective influence of beta-amyloid and APOE ε4 genotype on medial temporal lobe subregions in cognitively unimpaired older adults.
    de Flores R; Demeilliez-Servouin S; Kuhn E; Chauveau L; Landeau B; Delcroix N; Gonneaud J; Vivien D; Chételat G;
    Neurobiol Dis; 2023 Jun; 181():106127. PubMed ID: 37061167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma and brain immunoglobulin A in Alzheimer's disease is lost in apolipoprotein E ε4 carriers.
    Pocevičiūtė D; Nuñez-Diaz C; Roth B; Janelidze S; ; Giannisis A; Hansson O; Wennström M
    Alzheimers Res Ther; 2022 Aug; 14(1):117. PubMed ID: 36008818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial Activation and Connectivity in Alzheimer Disease and Aging.
    Rauchmann BS; Brendel M; Franzmeier N; Trappmann L; Zaganjori M; Ersoezlue E; Morenas-Rodriguez E; Guersel S; Burow L; Kurz C; Haeckert J; Tatò M; Utecht J; Papazov B; Pogarell O; Janowitz D; Buerger K; Ewers M; Palleis C; Weidinger E; Biechele G; Schuster S; Finze A; Eckenweber F; Rupprecht R; Rominger A; Goldhardt O; Grimmer T; Keeser D; Stoecklein S; Dietrich O; Bartenstein P; Levin J; Höglinger G; Perneczky R
    Ann Neurol; 2022 Nov; 92(5):768-781. PubMed ID: 36053756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial activation in Alzheimer disease: Association with APOE genotype.
    Egensperger R; Kösel S; von Eitzen U; Graeber MB
    Brain Pathol; 1998 Jul; 8(3):439-47. PubMed ID: 9669695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β-independent regulators of tau pathology in Alzheimer disease.
    van der Kant R; Goldstein LSB; Ossenkoppele R
    Nat Rev Neurosci; 2020 Jan; 21(1):21-35. PubMed ID: 31780819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E4 promotes the early deposition of Abeta42 and then Abeta40 in the elderly.
    Walker LC; Pahnke J; Madauss M; Vogelgesang S; Pahnke A; Herbst EW; Stausske D; Walther R; Kessler C; Warzok RW
    Acta Neuropathol; 2000 Jul; 100(1):36-42. PubMed ID: 10912918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts.
    Cacciaglia R; Salvadó G; Molinuevo JL; Shekari M; Falcon C; Operto G; Suárez-Calvet M; Milà-Alomà M; Sala A; Rodriguez-Vieitez E; Kollmorgen G; Suridjan I; Blennow K; Zetterberg H; Gispert JD; ;
    Mol Psychiatry; 2022 Apr; 27(4):2010-2018. PubMed ID: 35236958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.